CASP4 and non-small cell lung carcinoma: Instead, 17.31% of caspase-4 positive NSCLC patients (18 out of 104) did not have levels of LDH higher than 240 U/L, herein identified as LDH negative (LDH-) (Figure 1B, blue part).